A randomized double-blind, placebo-controlled pilot trial of heat-killed Bifidobacterium bifidum OLB6378 concentrate on fecal IgA levels in children and their parents

Abstract Objective This pilot study aimed to evaluate the effect of dietary heat-killed Bifidobacterium bifidum OLB6378 concentrate (OLB6378 concentrate) on gut IgA production during childhood and beyond. Results This study was designed as a randomized, double-blind, placebo-controlled pilot trial for children and their parents. After 2-week intake of placebo or OLB6378 drink, an overall analysis with a mixed model for repeated measures showed no significant difference in fecal IgA levels between the groups for children and parents (placebo vs. active: n = 18 vs. n = 15 in children, n = 18 vs. n = 17 in parents). The estimated effect sizes for the change in fecal IgA levels at week 2 were d = 0.32 (95% confidence interval [CI] = − 0.37–1.01) in children and d = − 0.19 (95% CI = − 0.85–0.48) in parents. In conclusion, 2-week supplementation with OLB6378 concentrate did not significantly increase fecal IgA levels in children or parents, although the study provided preliminary feasibility information for designing a future confirmatory trial in children. These findings are hypothesis-generating and provide preliminary data to determine parameter variance and sample size calculations for future larger-scale trials.

Authors

Institutions

Publication Details

Journal
BMC Research Notes
Published
2026-11-12
DOI
https://doi.org/10.1186/s13104-026-08095-9
Primary Topic
Probiotics and Fermented Foods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A randomized double-blind, placebo-controlled pilot trial of heat-killed Bifidobacterium bifidum OLB6378 concentrate on fecal IgA levels in children and their parents

Keigo Sato, Shinji Jinno, Megumu Igawa, Chiharu Tsutsumi
BMC Research Notes
Probiotics and Fermented Foods
article

A randomized double-blind, placebo-controlled pilot trial of heat-killed Bifidobacterium bifidum OLB6378 concentrate on fecal IgA levels in children and their parents

Keigo Sato, Shinji Jinno, Megumu Igawa, Chiharu Tsutsumi
article en

Abstract

Abstract Objective This pilot study aimed to evaluate the effect of dietary heat-killed Bifidobacterium bifidum OLB6378 concentrate (OLB6378 concentrate) on gut IgA production during childhood and beyond. Results This study was designed as a randomized, double-blind, placebo-controlled pilot trial for children and their parents. After 2-week intake of placebo or OLB6378 drink, an overall analysis with a mixed model for repeated measures showed no significant difference in fecal IgA levels between the groups for children and parents (placebo vs. active: n = 18 vs. n = 15 in children, n = 18 vs. n = 17 in parents). The estimated effect sizes for the change in fecal IgA levels at week 2 were d = 0.32 (95% confidence interval [CI] = − 0.37–1.01) in children and d = − 0.19 (95% CI = − 0.85–0.48) in parents. In conclusion, 2-week supplementation with OLB6378 concentrate did not significantly increase fecal IgA levels in children or parents, although the study provided preliminary feasibility information for designing a future confirmatory trial in children. These findings are hypothesis-generating and provide preliminary data to determine parameter variance and sample size calculations for future larger-scale trials.

BMC Research Notes
Meiji (Japan) (JP), Sagami Women's University (JP)
Food Science Institute Foundation
Good health and well-being, Zero hunger
Probiotics and Fermented Foods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon